Literature DB >> 19931640

Vitamin D receptor deletion leads to reduced level of IkappaBalpha protein through protein translation, protein-protein interaction, and post-translational modification.

Shaoping Wu1, Yinglin Xia, Xingyin Liu, Jun Sun.   

Abstract

Vitamin D receptor plays an essential role in the regulation of inflammation. Previous studies demonstrate that vitamin D receptor negatively modulates the proinflammatory NF-kappaB pathway. However, it is unknown how vitamin D receptor regulates IkappaBalpha, the endogenous inhibitor of NF-kappaB. Here we investigated the molecular mechanism of vitamin D receptor deletion and IkappaBalpha expression. We found that cells lacking vitamin D receptor had significantly increased levels of IkappaBalpha mRNA and simultaneously decreased levels of IkappaBalpha protein. Lacking vitamin D receptor abolished its binding to the IkappaBalpha promoter. Moreover, the levels of protein translation regulators and the rate of protein synthesis were both decreased in cells lacking vitamin D receptor. At the post-translational level, IkappaBalpha ubiquitination was enhanced, indicating increased degradation of IkappaBalpha in the absence of vitamin D receptor. We further transfected cells with a plasmid carrying either wild-type or mutant IkappaBalpha. The expression of wild-type IkappaBalpha was much higher in the cells with vitamin D receptor than in the cells without vitamin D receptor, whereas the expression of exogenous IkappaBalpha was equally high in both cell lines. In summary, vitamin D receptor deletion affects IkappaBalpha through mRNA transcription, protein translation, protein-protein interaction, post-translational modification, and protein degradation, thus reducing the level of IkappaBalpha protein. Cells lacking vitamin D receptor are known in a proinflammatory state with activation of NF-kappaB. Our study provides new insight into vitamin D receptor regulation of an inhibitor of NF-kappaB in inflammation. Deletion of vitamin D receptor contributes to the activation of NF-kappaB on multiple levels. Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19931640      PMCID: PMC2818560          DOI: 10.1016/j.biocel.2009.11.012

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  30 in total

Review 1.  Vitamin D analogs: mechanism of action and therapeutic applications.

Authors:  S Nagpal; J Lu; M F Boehm
Journal:  Curr Med Chem       Date:  2001-11       Impact factor: 4.530

Review 2.  The two NF-kappaB activation pathways and their role in innate and adaptive immunity.

Authors:  Giuseppina Bonizzi; Michael Karin
Journal:  Trends Immunol       Date:  2004-06       Impact factor: 16.687

Review 3.  Signaling to NF-kappaB.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Genes Dev       Date:  2004-09-15       Impact factor: 11.361

4.  The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses.

Authors:  David L Boone; Emre E Turer; Eric G Lee; Regina-Celeste Ahmad; Matthew T Wheeler; Colleen Tsui; Paula Hurley; Marcia Chien; Sophia Chai; Osamu Hitotsumatsu; Elizabeth McNally; Cecile Pickart; Averil Ma
Journal:  Nat Immunol       Date:  2004-08-29       Impact factor: 25.606

5.  De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling.

Authors:  Ingrid E Wertz; Karen M O'Rourke; Honglin Zhou; Michael Eby; L Aravind; Somasekar Seshagiri; Ping Wu; Christian Wiesmann; Rohan Baker; David L Boone; Averil Ma; Eugene V Koonin; Vishva M Dixit
Journal:  Nature       Date:  2004-07-18       Impact factor: 49.962

6.  A vitamin D analog down-regulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development.

Authors:  Nadia Giarratana; Giuseppe Penna; Susana Amuchastegui; Roberto Mariani; Kenn C Daniel; Luciano Adorini
Journal:  J Immunol       Date:  2004-08-15       Impact factor: 5.422

7.  A nucleosomal function for IkappaB kinase-alpha in NF-kappaB-dependent gene expression.

Authors:  Vasiliki Anest; Julie L Hanson; Patricia C Cogswell; Kris A Steinbrecher; Brian D Strahl; Albert S Baldwin
Journal:  Nature       Date:  2003-06-05       Impact factor: 49.962

8.  Lithocholic acid down-regulation of NF-kappaB activity through vitamin D receptor in colonic cancer cells.

Authors:  Jun Sun; Reba Mustafi; Sonia Cerda; Anusara Chumsangsri; Yinglin Rick Xia; Yan Chun Li; Marc Bissonnette
Journal:  J Steroid Biochem Mol Biol       Date:  2008-04-25       Impact factor: 4.292

9.  Vitamin D status in children, adolescents, and young adults with Crohn disease.

Authors:  Timothy A Sentongo; Edisio J Semaeo; Nicolas Stettler; David A Piccoli; Virginia A Stallings; Babette S Zemel
Journal:  Am J Clin Nutr       Date:  2002-11       Impact factor: 7.045

10.  Integration of the NfkappaB p65 subunit into the vitamin D receptor transcriptional complex: identification of p65 domains that inhibit 1,25-dihydroxyvitamin D3-stimulated transcription.

Authors:  Xianghuai Lu; Paul Farmer; Janet Rubin; Mark S Nanes
Journal:  J Cell Biochem       Date:  2004-07-01       Impact factor: 4.429

View more
  25 in total

1.  Vitamin D receptor pathway is required for probiotic protection in colitis.

Authors:  Shaoping Wu; Sonia Yoon; Yong-Guo Zhang; Rong Lu; Yinglin Xia; Jiandi Wan; Elaine O Petrof; Erika C Claud; Di Chen; Jun Sun
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-07-09       Impact factor: 4.052

2.  Vitamin D receptor is a novel transcriptional regulator for Axin1.

Authors:  Dapeng Jin; Yong-Guo Zhang; Shaoping Wu; Rong Lu; Zhijie Lin; Yuanyuan Zheng; Honglei Chen; Gabriella Cs-Szabo; Jun Sun
Journal:  J Steroid Biochem Mol Biol       Date:  2016-09-04       Impact factor: 4.292

3.  Vitamin D receptor negatively regulates bacterial-stimulated NF-kappaB activity in intestine.

Authors:  Shaoping Wu; Anne P Liao; Yinglin Xia; Yan Chun Li; Jian-Dong Li; R Balfour Sartor; Jun Sun
Journal:  Am J Pathol       Date:  2010-06-21       Impact factor: 4.307

4.  RNA-binding protein HuR regulates translation of vitamin D receptor modulating rapid epithelial restitution after wounding.

Authors:  Yunzhan Zhang; Jia-Zhong Cai; Lan Xiao; Hee K Chung; Xiang-Xue Ma; Lin-Lin Chen; Jaladanki N Rao; Jian-Ying Wang
Journal:  Am J Physiol Cell Physiol       Date:  2020-05-20       Impact factor: 4.249

5.  Deletion of vitamin D receptor leads to premature emphysema/COPD by increased matrix metalloproteinases and lymphoid aggregates formation.

Authors:  Isaac K Sundar; Jae-Woong Hwang; Shaoping Wu; Jun Sun; Irfan Rahman
Journal:  Biochem Biophys Res Commun       Date:  2011-02-12       Impact factor: 3.575

Review 6.  Vitamin D, vitamin D receptor, and macroautophagy in inflammation and infection.

Authors:  Shaoping Wu; Jun Sun
Journal:  Discov Med       Date:  2011-04       Impact factor: 2.970

7.  Fetal alcohol syndrome, chemo-biology and OMICS: ethanol effects on vitamin metabolism during neurodevelopment as measured by systems biology analysis.

Authors:  Bruno César Feltes; Joice de Faria Poloni; Itamar José Guimarães Nunes; Diego Bonatto
Journal:  OMICS       Date:  2014-05-09

8.  Intestinal epithelial vitamin D receptor deletion leads to defective autophagy in colitis.

Authors:  Shaoping Wu; Yong-Guo Zhang; Rong Lu; Yinglin Xia; David Zhou; Elaine O Petrof; Erika C Claud; Di Chen; Eugene B Chang; Geert Carmeliet; Jun Sun
Journal:  Gut       Date:  2014-07-30       Impact factor: 23.059

9.  Dietary vitamin D3 deficiency alters intestinal mucosal defense and increases susceptibility to Citrobacter rodentium-induced colitis.

Authors:  Natasha R Ryz; Arion Lochner; Kirandeep Bhullar; Caixia Ma; Tina Huang; Ganive Bhinder; Else Bosman; Xiujuan Wu; Sheila M Innis; Kevan Jacobson; Bruce A Vallance
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-09-03       Impact factor: 4.052

10.  Normalization of plasma 25-hydroxy vitamin D is associated with reduced risk of surgery in Crohn's disease.

Authors:  Ashwin N Ananthakrishnan; Andrew Cagan; Vivian S Gainer; Tianxi Cai; Su-Chun Cheng; Guergana Savova; Pei Chen; Peter Szolovits; Zongqi Xia; Philip L De Jager; Stanley Y Shaw; Susanne Churchill; Elizabeth W Karlson; Isaac Kohane; Robert M Plenge; Shawn N Murphy; Katherine P Liao
Journal:  Inflamm Bowel Dis       Date:  2013-08       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.